Company page

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc. (Ticker: KYMR) is a public company based in the United States, focused on developing innovative therapies through its proprietary technology. With a market capitalization of approximately $9.1 billion, Kymera is positioned in the biotechnology sector, aiming to address unmet medical needs. The company's advancements in drug development highlight its commitment to improving patient outcomes.